MDT
89.97
+0.71%↑
VEEV
275.84
-1.9%↓
A
123.3
-0.67%↓
WBA
11.51
-0.35%↓
HQY
94.45
-2.78%↓
MDT
89.97
+0.71%↑
VEEV
275.84
-1.9%↓
A
123.3
-0.67%↓
WBA
11.51
-0.35%↓
HQY
94.45
-2.78%↓
MDT
89.97
+0.71%↑
VEEV
275.84
-1.9%↓
A
123.3
-0.67%↓
WBA
11.51
-0.35%↓
HQY
94.45
-2.78%↓
MDT
89.97
+0.71%↑
VEEV
275.84
-1.9%↓
A
123.3
-0.67%↓
WBA
11.51
-0.35%↓
HQY
94.45
-2.78%↓
MDT
89.97
+0.71%↑
VEEV
275.84
-1.9%↓
A
123.3
-0.67%↓
WBA
11.51
-0.35%↓
HQY
94.45
-2.78%↓
24h
Current
Min
6.75
Max
7.32
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +146.19% upside |
Next Earnings | 11 sie 2025 |
---|
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
27 lis 2024, 13:34 UTC
CervoMed Shares Rise 15% on FDA's Orphan Drug Designation for Neflamapimod
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 17.75 USD 146.19%
High 21 USD
Low 15 USD
Based on 4 Wall Street analysts offering 12 month price targets forCervoMed Inc - Dist in the last 3 months.
By TipRanks
Strong Buy
4 ratings
4
Buy
0
Hold
0
Sell
Based on 4 analysts giving stock ratings to CervoMed Inc - Dist in the past 3 months.
$